Loading...
CVSA logo

Covista Inc.NYSE:CVSA 주식 보고서

시가총액 US$4.3b
주가
US$125.15
US$153.25
18.3% 저평가 내재 할인율
1Y-2.6%
7D1.8%
1D
포트폴리오 가치
보기

Covista Inc.

NYSE:CVSA 주식 리포트

시가총액: US$4.3b

CVSA Community Fair Values

Create Narrative

See what 27 others think this stock is worth. Follow their fair value or set your own to get alerts.

Covista Inc. 경쟁사

가격 이력 및 성과

Covista 주가의 최고가, 최저가 및 변동 요약
과거 주가
현재 주가US$125.15
52주 최고가US$156.26
52주 최저가US$86.97
베타0.63
1개월 변동16.28%
3개월 변동27.00%
1년 변동-2.61%
3년 변동195.93%
5년 변동244.01%
IPO 이후 변동10,168.72%

최근 뉴스 및 업데이트

새로운 내러티브 Apr 22

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

Catalysts About Covista Covista is a health care education provider focused on training nurses, physicians, veterinarians and behavioral health professionals at scale. What are the underlying business or industry changes driving this perspective?
새로운 내러티브 Apr 08

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

Catalysts About Covista Covista provides higher education programs focused on health care and related professional fields. What are the underlying business or industry changes driving this perspective?

Recent updates

새로운 내러티브 Apr 22

Health Care Workforce Shortages Will Pressure Capacity Expansion Yet Support Long Term Potential

Catalysts About Covista Covista is a health care education provider focused on training nurses, physicians, veterinarians and behavioral health professionals at scale. What are the underlying business or industry changes driving this perspective?
새로운 내러티브 Apr 08

Health Care Workforce Shortages And Digital Learning Will Support This Bullish Long Term Thesis

Catalysts About Covista Covista provides higher education programs focused on health care and related professional fields. What are the underlying business or industry changes driving this perspective?
새로운 내러티브 Mar 24

Health Care Workforce Shortages And Flexible Learning Will Support Stronger Long Term Outcomes

Catalysts About Covista Covista focuses on large scale health care education programs serving nursing, medical, veterinary and allied health students across the United States. What are the underlying business or industry changes driving this perspective?
Seeking Alpha Mar 13

Covista: A Mispriced Bet On The Healthcare Worker Shortage

Summary Covista is trading significantly below its intrinsic value despite short-term headwinds at Chamberlain University. All segments are growing revenue; Walden University’s 27% revenue and 13% enrollment growth offset Chamberlain’s 1% enrollment decline. Key risks include heavy reliance on Title IV funding and regulatory changes, though long-term healthcare demand and AI-driven career shifts support growth and limit risk. Read the full article on Seeking Alpha
분석 기사 Sep 27

With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
분석 기사 Aug 07

Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet

NYSE:ATGE 1 Year Share Price vs Fair Value Explore Adtalem Global Education's Fair Values from the Community and select...
분석 기사 Jul 07

An Intrinsic Calculation For Adtalem Global Education Inc. (NYSE:ATGE) Suggests It's 44% Undervalued

Key Insights Adtalem Global Education's estimated fair value is US$221 based on 2 Stage Free Cash Flow to Equity...
분석 기사 May 13

There's Reason For Concern Over Adtalem Global Education Inc.'s (NYSE:ATGE) Massive 27% Price Jump

Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders have had their patience rewarded with a 27% share price jump...
분석 기사 May 07

If EPS Growth Is Important To You, Adtalem Global Education (NYSE:ATGE) Presents An Opportunity

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
분석 기사 Apr 24

Is Adtalem Global Education (NYSE:ATGE) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 Mar 25

Adtalem Global Education Inc. (NYSE:ATGE) Shares Could Be 48% Below Their Intrinsic Value Estimate

Key Insights Adtalem Global Education's estimated fair value is US$198 based on 2 Stage Free Cash Flow to Equity...
분석 기사 Mar 11

Subdued Growth No Barrier To Adtalem Global Education Inc.'s (NYSE:ATGE) Price

With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for...
분석 기사 Feb 24

Is There Now An Opportunity In Adtalem Global Education Inc. (NYSE:ATGE)?

Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it saw a decent share price...
Seeking Alpha Feb 21

Adtalem Global Education: Surging On Registered Nurse Shortage

Summary Adtalem Global Education Inc.'s financial performance has surged with an underlying nationwide shortage of Registered Nurses and in mental health professionals. A shortage is expected to persist — Adtalem still looks to benefit from secular trends in an aging population, while the long-term performance depends on universities' ability to expand capacity. ATGE stock's surge already reflects a good mid-term earnings performance, making long-term growth required for significant returns. I estimate a fair value of $109.5. Read the full article on Seeking Alpha
분석 기사 Jan 21

With EPS Growth And More, Adtalem Global Education (NYSE:ATGE) Makes An Interesting Case

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
분석 기사 Dec 19

These 4 Measures Indicate That Adtalem Global Education (NYSE:ATGE) Is Using Debt Reasonably Well

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha Dec 17

Adtalem Global Education Still Offers Competitive PEG Ratio And Substantial Share Buybacks

Summary The company has shown significant financial progress with improving EBIT and profit margins, indicating efficient cost management. Current valuation metrics suggest the company is rather cheaply priced, despite the good run in 2024. The future outlook remains positive, but investors should be aware of potential risks, such as the debt or future competitive threats from robotics. Read the full article on Seeking Alpha
분석 기사 Nov 26

Adtalem Global Education Inc.'s (NYSE:ATGE) Shares Climb 27% But Its Business Is Yet to Catch Up

Adtalem Global Education Inc. ( NYSE:ATGE ) shareholders would be excited to see that the share price has had a great...
분석 기사 Oct 31

Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?

Adtalem Global Education Inc. ( NYSE:ATGE ), is not the largest company out there, but it led the NYSE gainers with a...
분석 기사 Oct 16

Should You Be Adding Adtalem Global Education (NYSE:ATGE) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Seeking Alpha Oct 04

Adtalem Global Education Faces Problems But Is Growing Steadily

Summary Adtalem Global Education focuses on medical and veterinary education, showing solid profitability and potential growth in a booming healthcare industry. Despite a current ratio below 1.0, ATGE maintains a reasonable price/book ratio and generates significant operating cash flow, indicating financial stability. Risks include reliance on government financial aid, maintaining accreditation, and ensuring student placements in healthcare jobs, which are crucial for sustaining reputation and revenue. With projected revenue growth and a forward P/E ratio of 13.12, Adtalem Global is a cautious buy, offering portfolio diversity in a growing sector. Read the full article on Seeking Alpha
분석 기사 Sep 16

Adtalem Global Education (NYSE:ATGE) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 Aug 29

Adtalem Global Education Inc.'s (NYSE:ATGE) Price In Tune With Earnings

With a price-to-earnings (or "P/E") ratio of 20.7x Adtalem Global Education Inc. ( NYSE:ATGE ) may be sending bearish...
분석 기사 Aug 14

We Think Adtalem Global Education's (NYSE:ATGE) Robust Earnings Are Conservative

Even though Adtalem Global Education Inc.'s ( NYSE:ATGE ) recent earnings release was robust, the market didn't seem to...
분석 기사 Jul 28

Should You Think About Buying Adtalem Global Education Inc. (NYSE:ATGE) Now?

While Adtalem Global Education Inc. ( NYSE:ATGE ) might not have the largest market cap around , it led the NYSE...
Seeking Alpha Jul 27

Adtalem Global Education: Still Undervalued After The Latest Rally

Summary Adtalem Global Education is set to report earnings on August 6th. The company specializes in healthcare education, with Chamberlain and Walden Universities under its wing, showing revenue growth post Walden acquisition. Financials show decent margins, but efficiency metrics trending down, with potential for top-line growth and margin expansion in the future. Read the full article on Seeking Alpha
분석 기사 Jul 12

Does Adtalem Global Education (NYSE:ATGE) Deserve A Spot On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
분석 기사 Jun 14

Adtalem Global Education (NYSE:ATGE) Has A Pretty Healthy Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seeking Alpha May 19

Adtalem Global Education: A Leading Healthcare Educator In A Growing Industry

Summary ATGE has demonstrated robust revenue growth and strong profit margins over the past three years. ATGE's 3Q24 earnings showed year-over-year revenue growth of 11.8%, driven by growth in enrollment and tuition rates. The healthcare industry is facing significant labour shortages, which are expected to impact hospitals growth targets and outlook. ATGE plays a crucial role in training and providing healthcare professionals. Read the full article on Seeking Alpha

주주 수익률

CVSAUS Consumer ServicesUS 시장
7D1.8%-1.1%1.1%
1Y-2.6%-25.4%28.7%

수익률 대 산업: CVSA은 지난 1년 동안 -25.4%의 수익을 기록한 US Consumer Services 산업보다 더 좋은 성과를 냈습니다.

수익률 대 시장: CVSA은 지난 1년 동안 28.7%를 기록한 US 시장보다 저조한 성과를 냈습니다.

주가 변동성

Is CVSA's price volatile compared to industry and market?
CVSA volatility
CVSA Average Weekly Movement6.1%
Consumer Services Industry Average Movement7.9%
Market Average Movement7.2%
10% most volatile stocks in US Market16.5%
10% least volatile stocks in US Market3.1%

안정적인 주가: CVSA는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.

시간에 따른 변동성: CVSA의 주간 변동성(6%)은 지난 1년 동안 안정적이었습니다.

회사 소개

설립직원 수CEO웹사이트
19874,727Steve Beardwww.covista.com

는 자회사와 함께 미국, 바베이도스, 세인트키츠, 세인트마틴에서 의료 교육을 제공하고 있습니다. 이 회사는 세 가지 부문으로 운영됩니다: 챔벌린, 월든, 의료 및 수의학입니다. 이 회사는 학사, 석사, 박사 학위를 포함한 학위 및 비학위 프로그램과 간호, 보건 전문직, 의학 및 수의학 고등 교육, 상담, 비즈니스, 정보 기술, 심리학, 공중 보건, 사회복지 및 인적 서비스, 공공 행정 및 공공 정책, 형사 사법을 위한 온라인 자격증 프로그램을 제공합니다.

Covista Inc. 기초 지표 요약

Covista의 순이익과 매출은 시가총액과 어떻게 비교됩니까?
CVSA 기초 통계
시가총액US$4.26b
순이익 (TTM)US$249.68m
매출 (TTM)US$1.91b
17.1x
주가수익비율(P/E)
2.2x
주가매출비율(P/S)

CVSA는 고평가되어 있습니까?

공정 가치 및 평가 분석 보기

순이익 및 매출

최근 실적 보고서(TTM)의 주요 수익성 지표
CVSA 손익계산서 (TTM)
매출US$1.91b
매출원가US$815.84m
총이익US$1.09b
기타 비용US$844.29m
순이익US$249.68m

최근 보고된 실적

Mar 31, 2026

다음 실적 발표일

해당 없음

주당순이익(EPS)7.34
총이익률57.28%
순이익률13.07%
부채/자본 비율36.6%

CVSA의 장기 실적은 어땠습니까?

과거 실적 및 비교 보기

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/24 16:25
종가2026/05/22 00:00
수익2026/03/31
연간 수익2025/06/30

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Covista Inc.는 23명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Gary BisbeeBarclays
Alexander ParisBarrington Research Associates, Inc.
Jeffrey SilberBMO Capital Markets Equity Research